Back to Browse Journals » Breast Cancer: Targets and Therapy

Breast Cancer: Targets and Therapy


Journal Articles:

- 195 records -

High glucose levels promote the proliferation of breast cancer cells through GTPases

Hou Y, Zhou M, Xie J, Chao P, Feng Q, Wu J

Breast Cancer: Targets and Therapy 2017, 9:429-436

Published Date: 13 June 2017

Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis

Delou JM, Vignal GM, Índio-do-Brasil V, Accioly MT, da Silva TS, Piranda DN, Sobral-Leite M, Carvalho MA, Capella MA, Vianna-Jorge R

Breast Cancer: Targets and Therapy 2017, 9:415-428

Published Date: 10 June 2017

Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohort

El Chediak A, Alameddine RS, Hakim A, Hilal L, Abdel Massih S, Hamieh L, Mukherji D, Temraz S, Charafeddine M, Shamseddine A

Breast Cancer: Targets and Therapy 2017, 9:407-414

Published Date: 10 June 2017

Single nucleotide polymorphisms and unacceptable late toxicity in breast cancer adjuvant radiotherapy: a case report

Lazzari G, Natalicchio MI, Terlizzi A, Perri F, Silvano G

Breast Cancer: Targets and Therapy 2017, 9:401-406

Published Date: 29 May 2017

SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer

Johnson R, Sabnis N, Sun X, Ahluwalia R, Lacko AG

Breast Cancer: Targets and Therapy 2017, 9:383-392

Published Date: 2 June 2017

The regulation of steroid receptors by epigallocatechin-3-gallate in breast cancer cells

Hallman K, Aleck K, Quigley M, Dwyer B, Lloyd V, Szmyd M, Dinda S

Breast Cancer: Targets and Therapy 2017, 9:365-373

Published Date: 24 May 2017

Effect of reduced dietary fat on estradiol, adiponectin, and IGF-1 levels in postmenopausal women with breast cancer

Murillo-Ortiz B, Martínez-Garza S, Cárdenas Landeros V, Cano Velázquez G, Suárez Garci­a D

Breast Cancer: Targets and Therapy 2017, 9:359-364

Published Date: 23 May 2017

Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro

Goyette S, Liang Y, Mafuvadze B, Cook MT, Munir M, Hyder SM

Breast Cancer: Targets and Therapy 2017, 9:347-357

Published Date: 19 May 2017

Current perspectives on CHEK2 mutations in breast cancer

Apostolou P, Papasotiriou I

Breast Cancer: Targets and Therapy 2017, 9:331-335

Published Date: 12 May 2017

Imprint cytology versus frozen section analysis for intraoperative assessment of sentinel lymph node in breast cancer

Petropoulou T, Kapoula A, Mastoraki A, Politi A, Spanidou-Karvouni E, Psychogios I, Vassiliou I, Arkadopoulos N

Breast Cancer: Targets and Therapy 2017, 9:325-330

Published Date: 5 May 2017

Prognostic value of histone chaperone FACT subunits expression in breast cancer

Attwood K, Fleyshman D, Prendergast L, Paszkiewicz G, Omilian AR, Bshara W, Gurova K

Breast Cancer: Targets and Therapy 2017, 9:301-311

Published Date: 3 May 2017

Metaplastic breast carcinoma with upper limb gangrene

Rajan R, Abdullah N, Abdullah NMA, Mohd Kassim AY

Breast Cancer: Targets and Therapy 2017, 9:297-299

Published Date: 2 May 2017

Improved immediate breast reconstruction as a result of oncoplastic multidisciplinary meeting

El Gammal MM, Lim M, Uppal R, Sainsbury R

Breast Cancer: Targets and Therapy 2017, 9:293-296

Published Date: 28 April 2017

Lymphoscintigraphy detecting alterations of upper limb lymphatic flow following early sentinel lymph node biopsy in breast cancer

Sarri AJ, Tinois da Silva E, Vieira RAC, Koga KH, Cação PHM, Sarri VC, Moriguchi SM

Breast Cancer: Targets and Therapy 2017, 9:279-285

Published Date: 19 April 2017

Mentha arvensis (Linn.)-mediated green silver nanoparticles trigger caspase 9-dependent cell death in MCF7 and MDA-MB-231 cells

Banerjee PP, Bandyopadhyay A, Harsha SN, Policegoudra RS, Bhattacharya S, Karak N, Chattopadhyay A

Breast Cancer: Targets and Therapy 2017, 9:265-278

Published Date: 18 April 2017

Intraoperative radiation therapy for breast cancer patients: current perspectives

Dutta SW, Showalter SL, Showalter TN, Libby B, Trifiletti DM

Breast Cancer: Targets and Therapy 2017, 9:257-263

Published Date: 18 April 2017

Effects of CYP2D6 and CYP3A5 polymorphisms on tamoxifen and its metabolites in Thai breast cancer patients

Charoenchokthavee W, Areepium N, Panomvana D, Sriuranpong V

Breast Cancer: Targets and Therapy 2017, 9:249-256

Published Date: 15 April 2017

Granular cell tumor in breast: a case report

Castillo Lara M, Martínez Herrera A, Torrejón Cardoso R, Lubián López DM

Breast Cancer: Targets and Therapy 2017, 9:245-248

Published Date: 11 April 2017

Tumescent mastectomy: the current indications and operative tips and tricks

Khater A, Mazy A, Gad M, Taha Abd Eldayem O, Hegazy M

Breast Cancer: Targets and Therapy 2017, 9:237-243

Published Date: 30 March 2017

The role of the chemokine receptor XCR1 in breast cancer cells

Yang XL, Qi LG, Lin FJ, Ou ZL

Breast Cancer: Targets and Therapy 2017, 9:227-236

Published Date: 29 March 2017

Breast cancer in patients with Li–Fraumeni syndrome – a case-series study and review of literature

Nandikolla AG, Venugopal S, Anampa J

Breast Cancer: Targets and Therapy 2017, 9:207-215

Published Date: 23 March 2017

Validation of Health Behavior and Stages of Change Questionnaire

Gonzalez-Ramirez LP, De la Roca-Chiapas JM, Colunga-Rodriguez C, Preciado-Serrano MDL, Daneri-Navarro A, Pedroza-Cabrera FJ, Martinez-Arriaga RJ

Breast Cancer: Targets and Therapy 2017, 9:199-205

Published Date: 22 March 2017

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

Jernström S, Hongisto V, Leivonen SK, Due EU, Tadele DS, Edgren H, Kallioniemi O, Perälä M, Mælandsmo GM, Sahlberg KK

Breast Cancer: Targets and Therapy 2017, 9:185-198

Published Date: 21 March 2017

The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells

Hallman K, Aleck K, Dwyer B, Lloyd V, Quigley M, Sitto N, Siebert AE, Dinda S

Breast Cancer: Targets and Therapy 2017, 9:153-161

Published Date: 10 March 2017

Mastectomy skin flap necrosis: challenges and solutions

Robertson SA, Jeevaratnam JA, Agrawal A, Cutress RI

Breast Cancer: Targets and Therapy 2017, 9:141-152

Published Date: 13 March 2017

Intensity modulated radiation therapy for breast cancer: current perspectives

Buwenge M, Cammelli S, Ammendolia I, Tolento G, Zamagni A, Arcelli A, Macchia G, Deodato F, Cilla S, Morganti AG

Breast Cancer: Targets and Therapy 2017, 9:121-126

Published Date: 6 March 2017

CYP2D6 polymorphisms may predict occurrence of adverse effects to tamoxifen: a preliminary retrospective study

Wickramage I, Tennekoon KH, Ariyaratne MAY, Hewage AS, Sundralingam T

Breast Cancer: Targets and Therapy 2017, 9:111-120

Published Date: 6 March 2017

An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors

Koleck TA, Bender CM, Clark BZ, Ryan CM, Ghotkar P, Brufsky A, McAuliffe PF, Rastogi P, Sereika SM, Conley YP

Breast Cancer: Targets and Therapy 2017, 9:95-110

Published Date: 3 March 2017

Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity

Sambi M, Haq S, Samuel V, Qorri B, Haxho F, Hill K, Harless W, Szewczuk MR

Breast Cancer: Targets and Therapy 2017, 9:85-93

Published Date: 28 February 2017

The predictors of poor quality of life in a sample of Saudi women with breast cancer

Ahmed AE, Alharbi AG, Alsadhan MA, Almuzaini AS, Almuzaini HS, Ali YZ, Jazieh AR

Breast Cancer: Targets and Therapy 2017, 9:51-58

Published Date: 9 February 2017

Docetaxel-associated myalgia–arthralgia syndrome in patients with breast cancer

Seguin C, Kovacevich N, Voutsadakis IA

Breast Cancer: Targets and Therapy 2017, 9:39-44

Published Date: 23 January 2017

Breast cancer in Mongolia: an increasingly important health policy issue

Demchig D, Mello-Thoms C, Brennan PC

Breast Cancer: Targets and Therapy 2017, 9:29-38

Published Date: 20 January 2017

Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women

Murillo-Ortiz B, Martínez-Garza S, Suárez García D, Castillo Valenzuela RDC, García Regalado JF, Cano Velázquez G

Breast Cancer: Targets and Therapy 2017, 9:21-27

Published Date: 13 January 2017

Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells

Cook MT, Liang Y, Besch-Williford C, Hyder SM

Breast Cancer: Targets and Therapy 2017, 9:9-19

Published Date: 23 December 2016

Gastric and colon metastasis from breast cancer: case report, review of the literature, and possible underlying mechanisms

Villa Guzmán JC, Espinosa J, Cervera R, Delgado M, Patón R, Cordero García JM

Breast Cancer: Targets and Therapy 2017, 9:1-7

Published Date: 23 December 2016

Expression and functionality of TRPV1 in breast cancer cells

Weber LV, Al-Refae K, Wölk G, Bonatz G, Altmüller J, Becker C, Gisselmann G, Hatt H

Breast Cancer: Targets and Therapy 2016, 8:243-252

Published Date: 13 December 2016

HMMR antisense RNA 1, a novel long noncoding RNA, regulates the progression of basal-like breast cancer cells

Liu W, Ma J, Cheng Y, Zhang H, Luo W, Zhang H

Breast Cancer: Targets and Therapy 2016, 8:223-229

Published Date: 24 November 2016

Tumor suppressor ING4 inhibits estrogen receptor activity in breast cancer cells

Keenen MM, Kim S

Breast Cancer: Targets and Therapy 2016, 8:211-221

Published Date: 17 November 2016

Are another 5 years of adjuvant aromatase inhibitor therapy needed?

Mo QG, Li DQ, Zhong JH, Wei CY

Breast Cancer: Targets and Therapy 2016, 8:207-209

Published Date: 14 November 2016

Statins and risk of breast cancer recurrence

Sakellakis M, Akinosoglou K, Kostaki A, Spyropoulou D, Koutras A

Breast Cancer: Targets and Therapy 2016, 8:199-205

Published Date: 4 November 2016

Current advances in biomarkers for targeted therapy in triple-negative breast cancer

Fleisher B, Clarke C, Ait-Oudhia S

Breast Cancer: Targets and Therapy 2016, 8:183-197

Published Date: 6 October 2016

Economic burden related to chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care system

Rashid N, Koh HA, Baca HC, Lin KJ, Malecha SE, Masaquel A

Breast Cancer: Targets and Therapy 2016, 8:173-181

Published Date: 4 October 2016

Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment

Charoenchokthavee W, Panomvana D, Sriuranpong V, Areepium N

Breast Cancer: Targets and Therapy 2016, 8:149-155

Published Date: 8 August 2016

Adjuvant systemic therapy in older women with breast cancer

Leone J, Leone BA, Leone JP

Breast Cancer: Targets and Therapy 2016, 8:141-147

Published Date: 25 July 2016

The absence of aldehyde dehydrogenase 1 A1-positive cells in benign mammary stroma is associated with risk factors for breast cancer

Isfoss BL, Holmqvist B, Jernström H, Alm P, Olsson H

Breast Cancer: Targets and Therapy 2016, 8:117-124

Published Date: 27 May 2016

Is radiation-induced ovarian ablation in breast cancer an obsolete procedure? Results of a meta-analysis

Al Asiri M, Tunio MA, Abdulmoniem R

Breast Cancer: Targets and Therapy 2016, 8:109-116

Published Date: 25 May 2016

Triple-negative breast cancer: treatment challenges and solutions

Collignon J, Lousberg L, Schroeder H, Jerusalem G

Breast Cancer: Targets and Therapy 2016, 8:93-107

Published Date: 20 May 2016

Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent

Hanlon KE, Lozano-Ondoua AN, Umaretiya PJ, Symons-Liguori AM, Chandramouli A, Moy JK, Kwass WK, Mantyh PW, Nelson MA, Vanderah TW

Breast Cancer: Targets and Therapy 2016, 8:59-71

Published Date: 15 April 2016

Breast cancer characteristics in very young Egyptian women ≤35 years

Farouk O, Ebrahim MA, Senbel A, Emarah Z, Abozeed W, Seisa MO , Mackisack S, Abdel Jalil S, Abdelhady S

Breast Cancer: Targets and Therapy 2016, 8:53-58

Published Date: 5 April 2016

Factors affecting local recurrence and distant metastases of invasive breast cancer after breast-conserving surgery in Chiang Mai University Hospital

Ditsatham C, Somwangprasert A, Watcharachan K, Wongmaneerung P, Khorana J

Breast Cancer: Targets and Therapy 2016, 8:47-52

Published Date: 18 March 2016

Astym therapy improves function and range of motion following mastectomy

Davies CC, Brockopp D, Moe K

Breast Cancer: Targets and Therapy 2016, 8:39-45

Published Date: 8 March 2016

Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer

Casneuf T, Axel AE, King P, Alvarez JD, Werbeck JL, Verhulst T, Verstraeten K, Hall BM, Sasser AK

Breast Cancer: Targets and Therapy 2016, 8:13-27

Published Date: 3 February 2016

Managing breast cancer in younger women: challenges and solutions

Ademuyiwa FO, Cyr A, Ivanovich J, Thomas MA

Breast Cancer: Targets and Therapy 2016, 8:1-12

Published Date: 21 December 2015

A GM-CSF and CD40L bystander vaccine is effective in a murine breast cancer model

Soliman H, Mediavilla-Varela M, Antonia SJ

Breast Cancer: Targets and Therapy 2015, 7:389-397

Published Date: 15 December 2015

Correlation of clinicopathological outcomes with changes in IHC4 status after NACT in locally advanced breast cancers: do pre-NACT ER/PR status act as better prognosticators?

Chatterjee S, Saha A, Arun I, Nayak SS, Sinha S, Agrawal S, Parihar M, Ahmed R

Breast Cancer: Targets and Therapy 2015, 7:381-388

Published Date: 10 December 2015

Optimal delivery of male breast cancer follow-up care: improving outcomes

Ferzoco RM, Ruddy KJ

Breast Cancer: Targets and Therapy 2015, 7:371-379

Published Date: 23 November 2015

Hypofractionated whole breast radiotherapy: current perspectives

Koulis TA, Phan T, Olivotto IA

Breast Cancer: Targets and Therapy 2015, 7:363-370

Published Date: 27 October 2015

Exercise after breast cancer treatment: current perspectives

Dieli-Conwright CM, Orozco BZ

Breast Cancer: Targets and Therapy 2015, 7:353-362

Published Date: 21 October 2015

Symptom report in detecting breast cancer-related lymphedema

Fu MR, Axelrod D, Cleland CM, Qiu Z, Guth AA, Kleinman R, Scagliola J, Haber J

Breast Cancer: Targets and Therapy 2015, 7:345-352

Published Date: 15 October 2015

Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer

Advani P, Cornell L, Chumsri S, Moreno-Aspitia A

Breast Cancer: Targets and Therapy 2015, 7:321-335

Published Date: 22 September 2015

Taxanes in the elderly patient with metastatic breast cancer

Yardley DA

Breast Cancer: Targets and Therapy 2015, 7:293-301

Published Date: 3 September 2015

Pathological response rate in hormone-positive breast cancer patients treated with neoadjuvant FEC and triweekly docetaxel: a case series

Kiba T, Morii N, Takahashi H, Ozaki S, Atsumi M, Masumoto F, Yamashiro H

Breast Cancer: Targets and Therapy 2015, 7:245-250

Published Date: 28 August 2015

Triple negative breast cancer: an Indian perspective

Akhtar M, Dasgupta S, Rangwala M

Breast Cancer: Targets and Therapy 2015, 7:239-243

Published Date: 14 August 2015

Molecular heterogeneity in adjacent cells in triple-negative breast cancer

Huebschman ML, Lane NL, Liu HY, Sarode VR, Devlin JL, Frenkel EP

Breast Cancer: Targets and Therapy 2015, 7:231-237

Published Date: 11 August 2015

Establishment and characterization of a receptor-negative, hormone-nonresponsive breast cancer cell line from an Iraqi patient

Al-Shammari AM, Alshami MA, Umran MA, Almukhtar AA, Yaseen NY, Raad K, Hussien AA

Breast Cancer: Targets and Therapy 2015, 7:223-230

Published Date: 7 August 2015

Accelerated partial breast irradiation with brachytherapy: patient selection and technique considerations

Trifiletti DM, Romano KD, Showalter SL, Reardon KA, Libby B, Showalter TN

Breast Cancer: Targets and Therapy 2015, 7:211-221

Published Date: 29 July 2015

Optical imaging for breast cancer prescreening

Godavarty A, Rodriguez S, Jung YJ, Gonzalez S

Breast Cancer: Targets and Therapy 2015, 7:193-209

Published Date: 20 July 2015

Identification of genes involved in breast cancer and breast cancer stem cells

Apostolou P, Toloudi M, Papasotiriou I

Breast Cancer: Targets and Therapy 2015, 7:183-191

Published Date: 15 July 2015

Importance of perforating vessels in nipple-sparing mastectomy: an anatomical description

Amanti C, Vitale V, Lombardi A, Maggi S, Bersigotti L, Lazzarin G, Nuccetelli E, Romano C, Campanella L, Cristiano L, Bartoloni A, Argento G

Breast Cancer: Targets and Therapy 2015, 7:179-181

Published Date: 14 July 2015

Safety and esthetic outcomes of therapeutic mammoplasty using medial pedicle for early breast cancer

Roshdy S, Hussein O, Khater A, Zuhdy M, El-Hadaad HA, Farouk O, Senbel A, Fathi A, Hamed E, Denewer A

Breast Cancer: Targets and Therapy 2015, 7:173-178

Published Date: 7 July 2015

Management of early breast cancer in older women: from screening to treatment

Elomrani F, Zine M, Afif M, L’annaz S, Ouziane I, Mrabti H, Errihani H

Breast Cancer: Targets and Therapy 2015, 7:165-171

Published Date: 7 July 2015

Development and psychometric testing of a breast cancer patient-profiling questionnaire

Gorini A, Mazzocco K, Gandini S, Munzone E, McVie G, Pravettoni G

Breast Cancer: Targets and Therapy 2015, 7:133-146

Published Date: 1 June 2015

Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis

Frugtniet B, Jiang WG, Martin TA

Breast Cancer: Targets and Therapy 2015, 7:99-109

Published Date: 24 April 2015

Critical analysis of the potential for microRNA biomarkers in breast cancer management

Graveel CR, Calderone HM, Westerhuis JJ, Winn ME, Sempere LF

Breast Cancer: Targets and Therapy 2015, 7:59-79

Published Date: 23 February 2015

Internalization: acute apoptosis of breast cancer cells using herceptin-immobilized gold nanoparticles

Rathinaraj P, Al-Jumaily AM, Huh DS

Breast Cancer: Targets and Therapy 2015, 7:51-58

Published Date: 10 February 2015

Breast cancer in Brazil: epidemiology and treatment challenges

Cecilio AP, Takakura ET, Jumes JJ, dos Santos JW, Herrera AC, Victorino VJ, Panis C

Breast Cancer: Targets and Therapy 2015, 7:43-49

Published Date: 29 January 2015

A comparison of letrozole and anastrozole followed by letrozole in breast cancer patients

Aphinives P, Vachirodom D, Thanapaisal C, Rangsrikajee D, Somintara O

Breast Cancer: Targets and Therapy 2015, 7:37-41

Published Date: 20 January 2015

Cardiac risk in the treatment of breast cancer: assessment and management

Valachis A, Nilsson C

Breast Cancer: Targets and Therapy 2015, 7:21-35

Published Date: 16 January 2015

Factors associated with contralateral preventive mastectomy

Yakoub D, Avisar E, Koru-Sengul T, Miao F, Tannenbaum SL, Byrne MM, Moffat F, Livingstone A, Franceschi D

Breast Cancer: Targets and Therapy 2015, 7:1-8

Published Date: 7 January 2015

Immunohistochemical analysis of aldehyde dehydrogenase isoforms and their association with estrogen-receptor status and disease progression in breast cancer

Opdenaker LM, Arnold KM, Pohlig RT, Padmanabhan JS, Flynn DC, Sims-Mourtada J

Breast Cancer: Targets and Therapy 2014, 6:205-209

Published Date: 12 December 2014

Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma

Haxho F, Allison S, Alghamdi F, Brodhagen L, Kuta VE, Abdulkhalek S, Neufeld RJ, Szewczuk MR

Breast Cancer: Targets and Therapy 2014, 6:191-203

Published Date: 9 December 2014

BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase

Larsen S, Butthongkomvong K, Manikhas A, Trishkina E, Poddubuskaya E, Matrosova M, Srimuninnimit V, Lindkær-Jensen S

Breast Cancer: Targets and Therapy 2014, 6:179-189

Published Date: 27 November 2014

Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer

Stenehjem DD, Yoo M, Unni SK, Singhal M, Bauer H, Saverno K, Quah C, Masaquel A, Brixner DI

Breast Cancer: Targets and Therapy 2014, 6:169-177

Published Date: 29 October 2014

Recent advances in the development of breast cancer vaccines

Milani A, Sangiolo D, Aglietta M, Valabrega G

Breast Cancer: Targets and Therapy 2014, 6:159-168

Published Date: 14 October 2014

Locoregional recurrence of triple-negative breast cancer: effect of type of surgery and adjuvant postoperative radiotherapy

Bayoumi Y, AbdelSamie A, Abdelsaid A, Radwan A

Breast Cancer: Targets and Therapy 2014, 6:151-158

Published Date: 10 September 2014

Effects of switching from anastrozole to letrozole, due to reimbursement policy, on the outcome of breast cancer therapy

Aphinives P, Vachirodom D, Thanapaisal C, Rangsrikajee D, Somintara O

Breast Cancer: Targets and Therapy 2014, 6:145-150

Published Date: 27 August 2014

Breast carcinomas: variations in sonoelastographic appearance

Fleury E, Assunção-Queiroz M, Roveda Jr D

Breast Cancer: Targets and Therapy 2014, 6:135-143

Published Date: 4 August 2014

Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer

Wohlrab J, Bangemann N, Kleine-Tebbe A, Thill M, Kümmel S, Grischke EM, Richter R, Seite S, Lüftner D

Breast Cancer: Targets and Therapy 2014, 6:115-122

Published Date: 1 August 2014

The role of peroxiredoxin II in chemoresistance of breast cancer cells

Wang T, Diaz AJG, Yen Y

Breast Cancer: Targets and Therapy 2014, 6:73-80

Published Date: 23 May 2014

Current strategies for the prevention of breast cancer

Advani P, Moreno-Aspitia A

Breast Cancer: Targets and Therapy 2014, 6:59-71

Published Date: 2 May 2014

Tamoxifen for women at high risk of breast cancer

Nazarali SA, Narod SA

Breast Cancer: Targets and Therapy 2014, 6:29-36

Published Date: 17 February 2014

Multidrug-resistant breast cancer: current perspectives

Martin HL, Smith L, Tomlinson DC

Breast Cancer: Targets and Therapy 2014, 6:1-13

Published Date: 10 January 2014

Breast cancer causes and treatment: where are we going wrong?

Seymour CB, Mothersill C

Breast Cancer: Targets and Therapy 2013, 5:111-119

Published Date: 3 December 2013

Enhanced radiation response in radioresistant MCF-7 cells by targeting peroxiredoxin II

Diaz AJG, Tamae D, Yen Y, Li JJ, Wang T

Breast Cancer: Targets and Therapy 2013, 5:87-101

Published Date: 11 October 2013

Benefits of multidisciplinary teamwork in the management of breast cancer

Taylor C, Shewbridge A, Harris J, Green JS

Breast Cancer: Targets and Therapy 2013, 5:79-85

Published Date: 30 August 2013

Effects of CYP2D6 and UGT2B7 polymorphisms on pharmacokinetics of tamoxifen in Thai breast cancer patients

Areepium N, Panomvana D, Rungwanonchai P, Sathaporn S, Voravud N

Breast Cancer: Targets and Therapy 2013, 5:73-78

Published Date: 22 August 2013

Emerging targeted combinations in the management of breast cancer

Lee RJ, Armstrong AC, Wardley AM

Breast Cancer: Targets and Therapy 2013, 5:61-72

Published Date: 13 August 2013

Contribution of toll-like receptor signaling pathways to breast tumorigenesis and treatment

Kidd LR, Rogers EN, Yeyeodu ST, Jones DZ, Kimbro KS

Breast Cancer: Targets and Therapy 2013, 5:43-51

Published Date: 28 June 2013

Population-based service mammography screening: the Icelandic experience

Sigurdsson K, Ólafsdóttir EJ

Breast Cancer: Targets and Therapy 2013, 5:17-25

Published Date: 9 May 2013

Dormancy in breast cancer

Banys M, Hartkopf AD, Krawczyk N, Kaiser T, Meier-Stiegen F, Fehm T, Neubauer H

Breast Cancer: Targets and Therapy 2012, 4:183-191

Published Date: 5 December 2012

Therapeutic reduction mammoplasty in large-breasted women with cancer using superior and superomedial pedicles

Denewer A, Shahatto F, Elnahas W, Farouk O, Roshdy S, Khater A, Hussein O, Teima S, Hafez M, Zidan S, Shams N, Kotb S

Breast Cancer: Targets and Therapy 2012, 4:167-172

Published Date: 25 October 2012

Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy

Abramson RG, Arlinghaus LR, Weis JA, Li X, Dula AN, Chekmenev EY, Smith SA, Miga MI, Abramson VG, Yankeelov TE

Breast Cancer: Targets and Therapy 2012, 4:139-154

Published Date: 11 October 2012

Potential of afatinib in the treatment of patients with HER2-positive breast cancer

Geuna E, Montemurro F, Aglietta M, Valabrega G

Breast Cancer: Targets and Therapy 2012, 4:131-137

Published Date: 27 August 2012

Sonomammographic characteristics of invasive lobular carcinoma

Kombar OR, Fahmy DM, Brown MV, Farouk O, El-Damshety O

Breast Cancer: Targets and Therapy 2012, 4:115-124

Published Date: 30 July 2012

Targeting γ-secretase in breast cancer

Han J, Shen Q

Breast Cancer: Targets and Therapy 2012, 4:83-90

Published Date: 21 June 2012

Role of pertuzumab in the treatment of HER2-positive breast cancer

Hubalek M, Brantner C, Marth C

Breast Cancer: Targets and Therapy 2012, 4:65-73

Published Date: 28 May 2012

Psychiatric morbidity among Egyptian breast cancer patients and their partners and its impact on surgical decision-making

El-Hadidy MA, Elnahas W, Hegazy MAF, Hafez MT, Refky B, Abdel Wahab KM

Breast Cancer: Targets and Therapy 2012, 4:25-32

Published Date: 6 March 2012

A triple negative breast cancer: what it is not!

Katakkar SB

Breast Cancer: Targets and Therapy 2012, 4:21-23

Published Date: 24 February 2012

Radiotherapy of early breast cancer in scleroderma patients: our experience with four cases and a short review of the literature

Kyrgias G, Theodorou K, Zygogianni A, Tsanadis K, Zervoudis S, Tzitzikas, Koukourakis M

Breast Cancer: Targets and Therapy 2012, 4:3-8

Published Date: 24 January 2012

Does Veritas® play a role in breast reconstruction? a case report

Borgognone A, Anniboletti T, De Vita F

Breast Cancer: Targets and Therapy 2011, 3:175-177

Published Date: 20 December 2011

Invasive breast cancer in Argentine women: association between risk and prognostic factors with antigens of a peptidic and carbohydrate nature

Demichelis SO, Isla-Larrain MT, Cermignani L, Alberdi CG, Segal-Eiras A, Croce MV

Breast Cancer: Targets and Therapy 2011, 3:161-173

Published Date: 20 December 2011

Aromatase inhibitors in the treatment of breast cancer in post-menopausal female patients: an update

Schneider RE, Barakat AY, Pippen JE, Osborne CR

Breast Cancer: Targets and Therapy 2011, 3:113-125

Published Date: 4 October 2011

Breast reconstruction: current and future options

Paul Jr H, Prendergast TI, Nicholson B, White S, Frederick WA

Breast Cancer: Targets and Therapy 2011, 3:93-99

Published Date: 17 August 2011

Emerging role of brain metastases in the prognosis of breast cancer patients

Hambrecht A, Jandial R, Neman J

Breast Cancer: Targets and Therapy 2011, 3:79-91

Published Date: 10 August 2011

The p53 breast cancer tissue biomarker in Indian women

Patil V, Tayade M, Pingale S, Dalvi S, Rajekar R, Deshmukh H, Patil S, Singhai R

Breast Cancer: Targets and Therapy 2011, 3:71-78

Published Date: 11 August 2011

Estrogen receptor (ER) and progesterone receptor (PgR) in breast cancer of Indian women

Patil AV, Bhamre RS, Singhai R, Tayade MB, Patil VW

Breast Cancer: Targets and Therapy 2011, 3:27-33

Published Date: 19 April 2011

Cancer biomarker HER-2/neu in breast cancer in Indian women

Singhai R, Patil VW, Patil AV

Breast Cancer: Targets and Therapy 2011, 3:21-26

Published Date: 29 March 2011

Triple-negative (ER, PgR, HER-2/neu) breast cancer in Indian women

Vinayak W Patil, Rajeev Singhai, Amit V Patil, et al

Breast Cancer: Targets and Therapy 2011, 3:9-19

Published Date: 16 March 2011

Role of trastuzumab in the management of HER2-positive metastatic breast cancer

Andrea Milani, Filippo Montemurro, Luisa Gioeni, et al

Breast Cancer: Targets and Therapy 2010, 2:93-109

Published Date: 24 November 2010

Lapatinib: new opportunities for management of breast cancer

Julia Liao, Michelle Gallas, Mark Pegram, et al

Breast Cancer: Targets and Therapy 2010, 2:79-91

Published Date: 15 November 2010

Adjuvant treatment of breast cancer in postmenopausal women: role of exemestane

Iain RJ Macpherson, Colin Lindsay, Peter Canney

Breast Cancer: Targets and Therapy 2010, 2:59-70

Published Date: 14 October 2010

HER2-positive male breast cancer: an update

Laura Ottini, Carlo Capalbo, Piera Rizzolo, et al

Breast Cancer: Targets and Therapy 2010, 2:45-58

Published Date: 4 October 2010

Progress in the development of a therapeutic vaccine for breast cancer

Andrew L Coveler, Nicole E Bates, Mary L Disis

Breast Cancer: Targets and Therapy 2010, 2:25-36

Published Date: 4 June 2010

Ixabepilone as monotherapy or in combination for the treatment of advanced breast cancer

Erin M Bertino, Bhuvaneswari Ramaswamy

Breast Cancer: Targets and Therapy 2010, 2:13-23

Published Date: 24 May 2010

Challenges in the development of future treatments for breast cancer stem cells

Shyam A Patel, Anicia Ndabahaliye, Philip K Lim, et al

Breast Cancer: Targets and Therapy 2010, 2:1-11

Published Date: 10 March 2010

EGFR may couple moderate alcohol consumption to increased breast cancer risk

Christopher P Mill, Julia A Chester, David J Riese II

Breast Cancer: Targets and Therapy 2009, 1:31-38

Published Date: 5 October 2009